News
Kotak Alts invests Rs 200 M in Cellogen Therapeutics
2+ hour, 1+ min ago (148+ words) May 18, 2026 | Monday | News Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early- to growth-stage life sciences and healthcare businesses, has made an investment of Rs 200 million in Delhi-based startup Cellogen…...
Datar Cancer Genetics receives landmark US FDA clearance for Cell Dx-Tissue assay
1+ day, 14+ hour ago (117+ words) May 16, 2026 | Saturday | News Nashik-based Datar Cancer Genetics (DCG), a global precision oncology company, has announced that its tissue-based comprehensive genomic profiling (CGP) assay for all solid tumours, Cell Dx-Tissue, has been cleared by the US Food and Drug Administration (US…...
Ameliorate Biotech's multi-diagnostic test receives CDSCO manufacturing approval
1+ day, 16+ hour ago (327+ words) Bio Spectrum India Ameliorate Biotech's multi-diagnostic test receives CDSCO manufacturing approval May 16, 2026 | Saturday | News Simultaneously detects dengue, malaria (including vivax and falciparum differentiation), chikungunya and their co-infections using a single blood sample India Health Fund (IHF)-supported rapid multi-diagnostic test,…...
CAR-T Therapy in India: Market challenges, opportunities and path to scalable manufacturing
2+ day, 3+ hour ago (712+ words) Bio Spectrum India CAR-T Therapy in India: Market challenges, opportunities and path to scalable manufacturing May 15, 2026 | Friday | Views | By Archana Ganesh, M. S. , Scientist II, Cellares Corporation, Bay Area, California One of the most encouraging developments in India's CGT ecosystem is the…...
Piramal Pharma Solutions unveils state-of-the-art payload-linker suite in US
3+ day, 2+ hour ago (358+ words) Bio Spectrum India Piramal Pharma Solutions unveils state-of-the-art payload-linker suite in US May 15, 2026 | Friday | News To significantly enhance the company's ability to support global payload-linker development and manufacturing Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO)…...
Lupin inaugurates advanced multidisciplinary neuro-rehabilitation centre in Delhi
3+ day, 2+ hour ago (345+ words) Bio Spectrum India Lupin inaugurates advanced multidisciplinary neuro-rehabilitation centre in Delhi May 15, 2026 | Friday | News Expands access to state-of-the-art, technology-enabled care for patients with neurological disorders in North India Global pharma major Lupin has announced the launch of Atharv Ability, its…...
CM Vijay declares war on synthetic drugs in Tamil Nadu
3+ day, 2+ hour ago (765+ words) May 15, 2026 | Friday | News A Growing Drug Crisis in Tamil Nadu LSD was originally synthesized in 1938 by Swiss chemist Albert Hofmann and is known for causing hallucinations, distorted thinking, panic attacks, and severe psychological effects. In India, LSD is classified as…...
Telangana propels to become $145 B Life Sciences Ecosystem
3+ day, 15+ hour ago (221+ words) May 14, 2026 | Thursday | News Telangana's life sciences ecosystem has achieved a landmark milestone, reaching'an estimated valuation of $145 billion, fuelled by'over Rs'84, 000 crore in investments over the past two years'the fastest expansion in the state's history. The Board unanimously commended CEO Shakthi…...
Roche Pharma launches Tecentriq" SC, India's first subcutaneous immunotherapy for lung cancer in India
3+ day, 19+ hour ago (38+ words) Bio Spectrum India Roche Pharma launches Tecentriq" SC, India's first subcutaneous immunotherapy for lung cancer in India May 14, 2026 | Thursday | News...
Agilent and Veeda Lifesciences open joint analytical Centre of Excellence in Bengaluru
4+ day, 10+ hour ago (306+ words) Bio Spectrum India Agilent and Veeda Lifesciences open joint analytical Centre of Excellence in Bengaluru May 13, 2026 | Wednesday | News Integrates mass spectrometry-driven workflows with advanced bioanalytical and clinical research capabilities Agilent Technologies has announced a strategic collaboration with Veeda Lifesciences to…...